Recent research, new market study and the current scenario as well as future market potential of „Global Gout Therapeutics Market 2016-2020″ globally.
About Gout Therapeutics
Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.
Technavios analysts forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Get The Sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/860271
Technavio’s report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Horizon Pharma
Takeda Pharmaceuticals
Other prominent vendors
Ablynx
Alder Biopharmaceuticals
Antares Pharma
Astellas Pharma
Boehringer Ingelheim
Can-Fite BioPharma
Celgene
Celltrion
ChemoCentryx
CymaBay Therapeutics
Eisai
Eli Lilly
Gilead Sciences
GlaxoSmithKline
Incyte
Ironwood Pharmaceuticals
JW Pharmaceutical
KaloBios Pharmaceuticals
Lexicon Pharmaceuticals
LG Life Sciences
Merck
Morphotek
Novartis
Novo Nordisk
Regeneron Pharmaceuticals
Sandoz
Sanofi
Santarus
Selecta Biosciences
Teijin Pharma
UCB
Vertex Pharmaceuticals.
Market driver
Introduction of novel urate-lowering agents
For a full, detailed list, view our report
Browse More In Vitro Diagnostics Market Research Reports: http://www.marketresearchreports.biz/category/28
Market challenge
Low physician and patient awareness
For a full, detailed list, view our report
Market trend
Focus on regenerative medicines
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
To View The Latest Industry Press Releases: http://www.marketresearchreports.biz/pressreleases
Contact
Tel: +1-518-621-2074
E-Mail: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/